tiprankstipranks
Trending News
More News >
COSMO Pharmaceuticals N.V. (GB:0RGI)
LSE:0RGI
UK Market

COSMO Pharmaceuticals N.V. (0RGI) Financial Statements

Compare
16 Followers

COSMO Pharmaceuticals N.V. Financial Overview

COSMO Pharmaceuticals N.V.'s market cap is currently CHF1.58B. The company's EPS TTM is CHF0.180462742; its P/E ratio is -496.80; and it has a dividend yield of 1.80%. COSMO Pharmaceuticals N.V. is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 104.85M€ 266.79M€ 92.78M€ 102.09M€ 65.07M
Gross Profit€ 48.78M€ 246.92M€ 53.44M€ 83.33M€ 49.93M
Operating Income€ -10.48M€ 148.88M€ 6.15M€ 28.06M€ 11.10M
EBITDA€ 2.36M€ 165.71M€ 19.70M€ 46.74M€ 17.81M
Net Income€ -3.63M€ 133.24M€ -4.93M€ 17.23M€ 21.67M
Balance Sheet
Cash & Short-Term Investments€ 122.66M€ 142.96M€ 50.27M€ 240.95M€ 222.21M
Total Assets€ 612.16M€ 646.77M€ 553.98M€ 759.59M€ 805.56M
Total Debt€ 4.26M€ 2.20M€ 1.84M€ 173.60M€ 169.92M
Net Debt€ -51.56M€ -42.09M€ -48.44M€ -12.23M€ -28.64M
Total Liabilities€ 123.36M€ 141.68M€ 124.94M€ 295.80M€ 292.88M
Stockholders' Equity€ 481.92M€ 498.33M€ 422.16M€ 456.93M€ 505.28M
Cash Flow
Free Cash Flow€ -15.85M€ 156.76M€ 18.31M€ 25.92M€ 4.11M
Operating Cash Flow€ -11.62M€ 162.41M€ 22.71M€ 33.23M€ 12.61M
Investing Cash Flow€ 49.85M€ -128.88M€ 42.30M€ 1.69M€ 24.86M
Financing Cash Flow€ -24.61M€ -40.22M€ -211.27M€ -46.13M€ -27.25M
Currency in EUR

COSMO Pharmaceuticals N.V. Earnings and Revenue History

COSMO Pharmaceuticals N.V. Debt to Assets

COSMO Pharmaceuticals N.V. Cash Flow

COSMO Pharmaceuticals N.V. Forecast EPS vs Actual EPS